IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.078
EU - Europa 8.612
AS - Asia 7.826
SA - Sud America 1.274
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 9
Totale 28.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.871
SG - Singapore 3.425
IE - Irlanda 1.684
UA - Ucraina 1.646
HK - Hong Kong 1.585
IT - Italia 1.251
BR - Brasile 1.073
RU - Federazione Russa 1.066
CN - Cina 1.022
VN - Vietnam 848
SE - Svezia 802
DE - Germania 669
FI - Finlandia 505
KR - Corea 286
GB - Regno Unito 277
TR - Turchia 222
FR - Francia 215
CA - Canada 110
AR - Argentina 81
PL - Polonia 78
IN - India 75
NL - Olanda 62
AT - Austria 58
BD - Bangladesh 58
CH - Svizzera 58
ES - Italia 55
MX - Messico 52
JP - Giappone 48
UZ - Uzbekistan 46
ZA - Sudafrica 46
BE - Belgio 45
EC - Ecuador 28
IQ - Iraq 28
LB - Libano 27
ID - Indonesia 26
VE - Venezuela 25
CZ - Repubblica Ceca 23
LT - Lituania 20
PK - Pakistan 20
GR - Grecia 19
MA - Marocco 18
PY - Paraguay 18
CL - Cile 17
SA - Arabia Saudita 14
EU - Europa 13
RO - Romania 13
EG - Egitto 12
MK - Macedonia 12
CO - Colombia 11
DZ - Algeria 11
AL - Albania 10
AZ - Azerbaigian 10
IR - Iran 10
KE - Kenya 10
AE - Emirati Arabi Uniti 8
JO - Giordania 8
PH - Filippine 8
RS - Serbia 8
UY - Uruguay 8
JM - Giamaica 7
BG - Bulgaria 6
KZ - Kazakistan 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
NP - Nepal 5
PS - Palestinian Territory 5
PT - Portogallo 5
AU - Australia 4
BH - Bahrain 4
CR - Costa Rica 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
CI - Costa d'Avorio 3
CU - Cuba 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
EE - Estonia 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
MG - Madagascar 2
MU - Mauritius 2
Totale 28.901
Salva come PNG Salva come JPEG
Città #
Singapore 2.148
Chandler 1.785
Dublin 1.673
Hong Kong 1.582
San Mateo 906
Jacksonville 901
Ashburn 536
Boardman 533
Santa Clara 474
Dong Ket 467
Altamura 434
Medford 416
Princeton 415
Perugia 348
Moscow 323
Lawrence 312
Wilmington 291
Seoul 267
Ann Arbor 265
Beijing 244
Des Moines 226
Andover 211
Munich 192
Izmir 191
Los Angeles 168
Ho Chi Minh City 151
Saint Petersburg 139
New York 133
Piscataway 100
São Paulo 97
Helsinki 91
The Dalles 85
Turku 80
Norwalk 76
Hanoi 74
Redmond 55
Dearborn 54
Woodbridge 52
Shanghai 50
Denver 46
London 46
San Paolo di Civitate 46
Houston 45
Rome 45
Tokyo 45
Brussels 44
Dallas 42
Brooklyn 40
Warsaw 39
Chicago 36
Frankfurt am Main 36
Johannesburg 34
Rio de Janeiro 34
Montreal 33
Stockholm 33
Nuremberg 32
Atlanta 30
San Diego 28
Chennai 27
Phoenix 27
Belo Horizonte 26
Orem 26
Poplar 26
Toronto 26
Falkenstein 25
Amsterdam 23
Columbus 23
Brasília 22
Da Nang 22
Mexico City 22
Milan 20
San Francisco 20
Boston 19
Curitiba 19
Den Haag 19
Porto Alegre 19
Tashkent 19
Ankara 17
Haiphong 17
Manchester 17
Falls Church 16
Guangzhou 16
Hải Dương 16
Ottawa 16
Vienna 16
Campinas 15
Secaucus 15
Olomouc 14
Amelia 13
Auburn Hills 13
Tianjin 13
Baghdad 12
Guayaquil 12
San Jose 12
Valencia 12
Charlotte 11
Dhaka 11
Narni 11
New Delhi 11
Ninh Bình 11
Totale 18.026
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 520
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 239
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 166
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 154
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 135
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 134
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 126
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 124
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 124
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 123
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 123
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 122
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 119
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 118
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 116
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 114
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 114
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 113
Beta 1-tubulin in human platelets: not simply a structural cell frame. 112
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 111
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 111
Nitric oxide and its antithrombotic action on the cardiovascular system 109
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 108
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 108
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 107
Effect of substituted stilbenes on platelet function 107
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 106
Platelets are essential for leukocyte recruitment in allergic inflammation. 106
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 105
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 104
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 103
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 103
Tardive gestosis: clinical observations. 102
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 102
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 101
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 101
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 99
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 99
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 99
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 99
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 98
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 98
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 98
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 97
Allergen induces the migration of platelets to lung tissue in allergic asthma. 97
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 95
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 95
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 95
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 95
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 94
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 94
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 94
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 94
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 94
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 94
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 93
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 91
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 91
Arterite temporale occulta: contributo casistico e revisione della letteratura 91
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 90
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 90
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 90
Anti-platelet treatments in cancer: Basic and clinical research 90
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 89
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 89
Anti-platelet therapy: phosphodiesterase inhibitors. 89
Choline plasmalogen biosynthesis by transmethylation in human platelets 88
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 88
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 88
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 87
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 87
Effect of different plasma expanders on erythrocyte filterability 87
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 87
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 87
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 87
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 86
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH 86
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 86
[Occult temporal arteritis. Case reports and review of the literature]. 86
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 85
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 85
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 85
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 85
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 85
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 85
Matrix metalloproteinases and peripheral arterial disease. 84
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 84
Effects of resveratrol and other wine polyphenols on vascular function: an update. 84
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 84
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 83
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 83
Platelets 82
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 82
Platelet thromboxane A2 receptor number and function in normal and in hypertensive pregnancy. 81
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 81
Effect of GOFA nanocrystals on human monocyte cyclooxygenase-2. 81
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 80
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 80
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. 80
Effect of pentoxifylline on platelet aggregation 80
Totale 10.380
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.764 0 0 0 0 0 135 278 28 396 110 299 518
2021/20223.196 75 630 79 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/20266.085 819 737 604 1.493 1.632 800 0 0 0 0 0 0
Totale 29.769